title: Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells.
abstract: MCF10A mammary epithelial cells form growth-arrested structures when cultured in three-dimensional basement membrane gels. Activation of the receptor tyrosine kinase ErbB2 induces formation of proliferative structures that share properties with noninvasive early stage lesions. We conducted a genetic screen to identify cDNAs that can cooperate with ErbB2 to induce migration in these cells, with the hypothesis that they would represent candidate "second hits" in the development of invasive breast carcinomas. We found that expression of transforming growth factor (TGF)beta1 and TGFbeta3 in cells expressing activated ErbB2 induces migration in transwell chambers and invasive behavior in both basement membrane cultures and invasion chambers. The ability of ErbB2 to cooperate with TGFbeta correlated with sustained, elevated activation of extracellular signal-regulated kinase (Erk)-mitogen-activated protein kinase. Pharmacological reduction of Erk activity inhibited the cooperative effect of TGFbeta and ErbB2 on migration and expression of activated Erk kinase was sufficient to cooperate with TGFbeta to induce migration and invasion, suggesting that sustained Erk activation is critical for ErbB2/TGFbeta cooperation. In addition, we show that costimulation of ErbB2 and TGFbeta induces autocrine secretion of factors that are sufficient to induce migration, but not invasion, by means of both epidermal growth factor receptor-dependent and -independent processes. These results support the role of TGFbeta as a pro-invasion factor in the progression of breast cancers with activated ErbB2 and suggest that activation of the Erk and epidermal growth factor receptor pathways are key in mediating these events.
authors.affiliation: Department of Cell Biology and Harvard Institute of Proteomics, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA.
authors.forename: Sarah E
authors.initials: SE
authors.lastname: Seton-Rogers
authors.forename: Yu
authors.initials: Y
authors.lastname: Lu
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Hines
authors.forename: Malvika
authors.initials: M
authors.lastname: Koundinya
authors.forename: Joshua
authors.initials: J
authors.lastname: LaBaer
authors.forename: Senthil K
authors.initials: SK
authors.lastname: Muthuswamy
authors.forename: Joan S
authors.initials: JS
authors.lastname: Brugge
mesh_terms: D001943:Breast Neoplasms / Q000473:pathology*; D002465:Cell Movement; D004847:Epithelial Cells / Q000473:pathology; D005260:Female; D006801:Humans; D020928:Mitogen-Activated Protein Kinases / Q000502:physiology; D009361:Neoplasm Invasiveness; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000502:physiology*; D016212:Transforming Growth Factor beta / Q000502:physiology*; D014407:Tumor Cells, Cultured
chemical_list: D020928:Mitogen-Activated Protein Kinases; D018719:Erb-b2 Receptor Tyrosine Kinases; D016212:Transforming Growth Factor beta